Geode Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $180M | Buy |
|
|||||
2023
Q3 | $92.2M | Buy |
|
|||||
2023
Q2 | $105M | Sell |
|
|||||
2023
Q1 | $109M | Buy |
|
|||||
2022
Q4 | $105M | Buy |
|
|||||
2022
Q3 | $114M | Buy |
|
|||||
2022
Q2 | $53.7M | Buy |
|
|||||
2022
Q1 | $50.4M | Buy |
|
|||||
2021
Q4 | $50.8M | Buy |
|
|||||
2021
Q3 | $45.1M | Buy |
|
|||||
2021
Q2 | $40.9M | Buy |
|
|||||
2021
Q1 | $35.4M | Buy |
|
|||||
2020
Q4 | $26M | Buy |
|
|||||
2020
Q3 | $19.2M | Buy |
|
|||||
2020
Q2 | $22.9M | Buy |
|
|||||
2020
Q1 | $12.3M | Buy |
|
|||||
2019
Q4 | $6.69M | Buy |
|
|||||
2019
Q3 | $1.14M | Buy |
|